Image Credits: Canva
Heart attacks and strokes are among the leading causes of death globally, with millions suffering from cardiovascular diseases (CVD) every year. There are more than seven million people in the UK alone, with about 100,000 patients experiencing heart attacks annually. However, a group of researchers at University College London (UCL) estimate that one 'polypill' taken daily day could eliminate a majority of these cases dramatically lowering death tolls.
The proposed polypill, a combination of a statin and three blood pressure-lowering drugs, has been under study for over two decades. Experts argue that introducing this pill universally for individuals aged 50 and above could be more effective than the current NHS Health Check, which assesses risk factors every five years for those aged between 40 and 74.
Studies have repeatedly proven the effectiveness of the polypill in preventing CVD. A groundbreaking 2019 study in The Lancet found that five years' use of the polypill cut the risk of heart attack and stroke by a third. In addition, previous modelling analyses have estimated that if given universally to people over 55, the polypill might be able to prevent 80% of heart attacks and strokes.
Today, the NHS Health Check follows a risk-based model in which patients are tested for CVD risk factors and treated with drugs accordingly. Yet, as per UCL's study, this system has serious flaws:
Low Uptake: Just 40% of those eligible for the NHS Health Check choose to have it, leaving a considerable number of at-risk patients undiagnosed and untreated.
Ineffective Prediction of Risk: The majority of heart attacks and strokes happen to people at average risk levels, thus making it challenging to identify the need for intervention effectively.
Limited Effectiveness: Even at maximum take-up, the NHS Health Check programme is predicted to have fewer health impacts compared to a polypill initiative applied to the whole population.
One of the big benefits of the polypill is that it is so easy. In contrast to the existing screening-based model, the polypill scheme would not involve complicated medical tests or lengthy risk assessments. Instead, people reaching 50 would just have to fill out a few questions to determine possible side effects before they were prescribed.
Professor Aroon Hingorani of the UCL Institute of Cardiovascular Science, one of the strongest proponents of this scheme, says:
"Finally, the time is now to do much better on prevention. A population approach would prevent a lot more heart attacks and strokes than is done today with a strategy of trying to target a smaller group only."
Aside from the possible health implications, the polypill is also an economic solution. The drugs used are off-patent, thus cheap to produce and distribute. With the vast economic cost of managing CVD-related illnesses, a preventive model could result in substantial cost-saving for the NHS in the future.
The polypill has been proven to be effective by numerous international trials. In 2019, a randomised trial in rural Iran discovered that participants who took the polypill for five years had a 34% reduced risk of having a heart attack or stroke compared to non-participants.
Likewise, modelling research has indicated that even if only 8% of people aged over 50 took up the polypill regimen, it would still be more beneficial to their health than the NHS Health Check programme.
One of the main objections to the polypill strategy is the suggestion that it might result in the unnecessary medicalisation of a significant proportion of the population. But, it is argued, it should be considered as a preventative measure, not as mass medication.
Professor Sir Nicholas Wald of UCL's Institute of Health Informatics explains:
"Instead of being a 'medicalisation' of a significant proportion of the population, a polypill programme is a prevention measure to prevent an individual from becoming a patient."
He compares it with public health measures like water fluoridation or compulsory seatbelts—interventions that have been shown to have a significant impact in reducing public health danger at low individual cost.
With the evidence in favour of the polypill's effectiveness and viability overwhelming, experts are calling on the NHS to act now. It is their belief that substituting the NHS Health Check with a polypill-based prevention program could be the UK government's flagship policy under its pledge to put disease prevention ahead of cure.
As Professor Hingorani points out, "The status quo is not a justifiable option." With CVD still a major cause of death globally, taking a population-wide polypill approach could be a turning point for preventative medicine, potentially saving thousands of lives annually. The question now is whether the NHS will take up this call and establish a policy with the potential to transform the prevention of cardiovascular disease on a national level.
Credit: iStock
While you may be buying fast-fashion clothes that are easy on your pocket and also give your children trendy looks, a new study highlights the risk of being laced with a highly toxic ingredient: lead.
The preliminary research, based on lab tests of several shirts from different retailers in the US, found that all the samples exceeded the country’s federal regulatory lead limits.
The US Consumer Product Safety Commission currently has a 100 parts per million (ppm) lead limit for children's products like toys and clothing.
"I started to see many articles about lead in clothing from fast fashion, and I realized not too many parents knew about the issue," said Kamila Deavers, principal investigator of the study, at Marian University in the US.
Deavers began the study after her young daughter’s lab reports showed elevated levels of lead in her blood from toy coatings.
How was study conducted?
The team tested 11 shirts that spanned the rainbow—red, pink, orange, yellow, gray, and blue. All brightly colored fabrics, particularly reds and yellows, showed higher levels of lead compared to more muted tones.
"We saw that the shirts we tested were all over the allowed limit for lead of 100 ppm," said Priscila Espinoza, from Marina.
The researchers explained that some manufacturers use lead (II) acetate as an inexpensive way to help dyes stick to the materials and produce bright, long-lasting color.
The researchers found the risk is particularly higher among younger kids as they tend to playfully suck or chew their clothes during play.
"Even briefly chewing these fabrics could expose children to dangerous lead levels,” they found in the study, to be presented at the forthcoming meeting of the American Chemical Society.
According to the US Environmental Protection Agency (EPA), lead exposure can lead to behavior problems, brain and central nervous system damage, as well as other negative health effects in children.
The agency considers children under six years old to be most at risk from exposure. Even low levels of lead in the blood of children can result in:
The researchers also pointed out safer alternatives to lead-based dyeing agents that already exist. These include natural and less harmful substances such as:
Credit: X/Arvind Sharma
In a surprising video, a woman who ordered a tub of Kwality Wall's Frozen Dessert - Fruit & Nut in Rajasthan found the bottom of the container filled mostly with oil, raising questions about the quality of the product.
In the clip, the distressed customer was heard saying: "It is not even melting and has a weird flavor. I am never eating this ice cream again. I have asked my husband not to purchase this again. It was my favourite ice cream, but now I feel very disappointed."
However, after the post went viral, many X users pointed out that the brand sells frozen dessert, instead of ice cream and that frozen dessert contains palm oil which could explain why she found oil floating inside the container.
As the video continued to go viral across the country, an official spokesperson of Kwality Walls India Limited confirmed that an investigation had been launched into the product's quality.
Speaking about what could have gone wrong, they told NDTV: "Given that ice cream/frozen dessert requires a continuous cold chain from factory to outlet and then to the freezer at consumers' homes, and as it is a sensitive product, temperature variations-especially during peak summer-can impact it.
"We are closely examining all stages of the supply chain for any deviations in storage or handling at the front end. We continue to work with our partners to ensure strict adherence to temperature-controlled protocols until the product reaches consumers' homes."
READ MORE: Zepto Customer Claims To Find 'Plastic' Inside Eggs, FSSAI Says Impossible
Ice cream is essentially defined a frozen food dessert made from dairy products, such as milk and cream. For a product to qualify as ice cream, it has to contain atleast 10 percent milk fat and have a rich, creamy texture.
Often, natural color is used in ice cream to enhance its visual appeal, maintaining a healthier alternative to artificial dyes. The process involves churning a sweetened mixture of cream, milk, and flavors while freezing, incorporating air to create a light and airy consistency.
On the other hand, frozen desserts are typically made of a mixture of fats (vegetable oil or milk fat), sweeteners (sugar, glucose), milk solids and stabilizers/emulsifiers to create a smooth, creamy texture. They include diverse range of options, from fruit-based sorbets to creamy non-dairy alternatives.
Unlike ice creams, frozen desserts often use vegetable fats like palm oil, along with additives to manage texture and hold their shape longer when melting, and often have higher stabilizer content.
Due to being made from hydrogenated vegetable oils as well as are high in added sugars, saturated fats and processed ingredients, most frozen desserts are not considered healthy.
While some options have lower calories or fat than traditional ice cream, they are considered ultra-processed treats.
Experts recommend looking for fewer ingredients, less sugar, and dairy-based rather than palm-oil-based options as well as opting for single-serve items like small bars or cups to avoid overeating to stay healthy.
Credit: iStock
From higher costs on syringes, catheters, and MRIs, to medical supply shortages and longer wait times, the increasing geopolitical tensions around the Strait of Hormuz, which is likely to prolong, can spell trouble for the healthcare industry.
Amid a 48-hour "ultimatum" from US President Donald Trump to "fully open" the crucial waterway, Iran on Sunday said the Strait of Hormuz remains open to all shipping except that of its “enemies”.
The ongoing conflict has already spiked prices for medical devices—specifically plastics for syringes and catheters – due to the rising cost of raw materials. If disruptions persist, it can also warn of potential shortages, experts told HealthandMe.
In a statement, the Association of Indian Medical Device Industry (AiMeD) noted that the medical device input costs have already risen by nearly 50 percent for critical plastics, over 20 percent for packaging, and self-generated power running on diesel. It noted that PNG gas prices used for power generation and process heating have nearly doubled due to reduced availability.
This is eroding razor-thin margins on essentials like syringes, nitrile gloves, catheters, and plastic disposable medical devices in a highly competitive, volume-driven market.
“A shortage of liquid helium could impact the installation of new MRI scanners, each of which requires around 1,500 liters for the initial magnet fill. Supply disruptions linked to the war may delay new installations and push up costs, as helium prices are likely to rise amid tighter availability,” Dr. Harsh Mahajan, Mentor FICCI & Founder Mahajan Imaging & Labs, told HealthandMe.
Also read: Middle East Crisis Disrupting Health Services, Fueling Diseases & Environmental Hazards: WHO
The expert noted that there is no immediate concern for existing MRI machines.
It is because most currently installed scanners use K4 technology with zero boil-off systems, allowing them to operate efficiently without frequent helium refills.
“Typically, a top-up is needed only once every three years, when the magnet’s cold head is replaced. As a result, the existing installed base is expected to continue functioning without disruption in the near term,” Dr. Mahajan said.
According to experts, while one to three week shipment delays are manageable via buffers, prolonged disruptions risk production halts, hospital shortages, and costs due to inflated prices from market abuse by dominant large raw materials players.
Rajiv Nath, Forum Coordinator, AiMeD, has assured that “as of now, there are no shortages of syringes or other medical disposables, contrary to circulating rumors—there is no need to panic”.
While many manufacturers have adjusted product pricing by 10-20 percent to sustain operations, there is no acute shortage in key polymer grades like Polypropylene, HDPE, or LDPE, he added.
Also read: Black Rain Over Iran's Capital Tehran Sparks Health Fears
Long-term Hormuz Blockade Can Affect Critical Medical Supplies
However, the rapidly deteriorating situations and a longer blockade of Hormuz can lead to “substantial price increases, longer lead times, and highly elevated freight costs, which are pressuring cost structures and planning cycles”.
Nath said evolving global supply chain dynamics require close monitoring to prevent impacts on production timelines and industry stability.
The Medical Technology Association of India (MTaI) also warned that the ongoing US/Israel-Iran conflict and disruption in the Strait of Hormuz directly threaten India’s access to critical and life-saving medical technologies.
"Modern healthcare systems operate on just-in-time inventory models with minimal buffer stock. When large consignments - like those shipped by sea - are delayed or stranded, there is simply not enough inventory in the system to compensate, even through costlier alternatives like air freight," Pavan Choudary, Chairman, MTaI, told HealthandMe.
He also noted that shipment delays beyond March 31 can lead to "budget lapse, forcing a fresh approval cycle - thereby compounding delays that often stretch to months".
It is because many public institutions in India front-load procurement toward the financial year-end.
The industry experts urged the government to take urgent action to safeguard over 5 lakh jobs, ensure affordable healthcare access under Atmanirbhar Bharat, and protect exports to the US and EU.
The AiMeD also urged the Indian government not to reduce import duties on medical devices based on rumors of shortages.
© 2024 Bennett, Coleman & Company Limited